Integrated neuromuscular inhibition technique versus instrument assisted soft tissue mobilization on chronic mechanical neck pain

Effect of integrated neuromuscular inhibition technique versus instrument assisted soft tissue mobilization on chronic mechanical neck pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202102626402431

Enrollment

Registered

2021-02-15

Start date

2020-09-08

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Conventional physical therapy program

Integrated neuromuscular inhibition technique

Instrument assissted sot tissue mobilization

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects will be selected according to the following criteria: 1- The subjects’ age ranged from 18-38 years (Nagrale et al., 2010). 2- All subjects diagnosed as chronic mechanical neck pain 3- Patients from both genders. 4- The severity of pain on a numerical pain rating scale should be higher than two out of ten (Hussain et al., 2016). 5- Pain and stiffness last for at least 3 months (Reid et al., 2013). 6- Patients will be selected from the Physical Therapy Department in Omrania Medicine Center, Giza, Ministry Of Health, Egypt 7- Consent to participate in the study and follow the treatment schedule.

Exclusion criteria

Exclusion criteria: The subjects will be excluded according to the following criteria (Gulick, 2018): 1. Sensory problems in the upper or mid-back regions. 2. Heart or circulation problems. 3. Cancer, diabetes mellitus, or tuberculosis. 4. Any shoulder, neck, or upper/mid back surgeries. 5. The upper or mid-back region was inspected for wounds, lesions, or infections. 6. It was confirmed that each participant was free of current upper quarter injury and was not being treated for any injury in this area (including medication). 7. Exhibiting inadequate cooperation. 8. Infections 9. Inflammatory disorders. 10. Cervical degenerative joint disease. 11. Autoimmune conditions (rheumatoid arthritis, fibromyalgia). 12. If they had receive trigger point injections in the upper trapezius muscle within the past 6 months.

Design outcomes

Primary

Measure	Time frame
Cervical range of motion	—

Secondary

Measure	Time frame
Pain intensity level;Pressure pain threshold;Neck functional level	—

Countries

Egypt

Contacts

Public ContactRania Reda

Lecturer of Physical Therapy

raniareda22@hotmail.com+201001097571

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026